V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210037668 | 210006835 | 1.76 | null | Curative (C) | 2015-12-06 | 2015-12-10 | Methotrexate intrathecal | N | N | 210011161 | METHOTREXATE INTRATHECAL |
| 210037670 | 210006848 | 1.78 | null | Curative (C) | 2017-03-06 | 2017-10-14 | Methotrexate intrathecal | 02 | N | 210011203 | METHOTREXATE INTRATHECAL |
| 210037671 | 210006857 | 1.13 | 82 | Curative (C) | null | 2015-01-08 | Methotrexate intrathecal | 2 | null | 210011218 | METHOTREXATE INTRATHECAL |
| 210037672 | 210006861 | 0 | 17.1 | null | 2018-06-10 | 2018-06-12 | Methotrexate intrathecal | N | N | 210011220 | METHOTREXATE INTRATHECAL |
| 210037673 | 210006869 | 1.08 | null | Curative (C) | 2014-09-08 | 2015-03-06 | Methotrexate Intrathecal (any age) | Y | N | 210011259 | METHOTREXATE INTRATHECAL |
| 210037675 | 210006874 | 1.8 | 52.9 | Curative (C) | 2016-03-03 | 2016-06-24 | Methotrexate intrathecal | 02 | N | 210011276 | METHOTREXATE INTRATHECAL |
| 210037676 | 210034822 | 1.63 | 65.15 | Curative (C) | 2015-01-04 | 2015-01-04 | Methotrexate Intrathecal (any age) | Y | null | 210011282 | METHOTREXATE INTRATHECAL |
| 210037677 | 210030425 | 1.7 | null | Curative (C) | 2014-06-23 | 2014-06-28 | Methotrexate intrathecal | N | N | 210011346 | METHOTREXATE INTRATHECAL |
| 210037678 | 210006897 | 1.43 | 28.5 | Curative (C) | 2016-07-29 | 2018-11-23 | Methotrexate intrathecal | N | N | 210011355 | METHOTREXATE INTRATHECAL |
| 210037679 | 210025934 | null | 14.8 | Curative (C) | 2017-08-06 | 2017-08-06 | Methotrexate Intrathecal (any age) | N | N | 210011405 | METHOTREXATE INTRATHECAL |
| 210037680 | 210018736 | 1.69 | 55 | null | null | 2018-07-08 | Methotrexate Intrathecal (any age) | Y | null | 210011458 | METHOTREXATE INTRATHECAL |
| 210037681 | 210018743 | 1.69 | 13.75 | Curative (C) | 2017-07-08 | 2017-10-14 | Methotrexate Intrathecal (any age) | Y | N | 210011483 | METHOTREXATE INTRATHECAL |
| 210037682 | 210018749 | 1.83 | 0 | Curative (C) | 2016-05-06 | 2016-05-06 | Methotrexate Intrathecal (any age) | N | N | 210011540 | METHOTREXATE INTRATHECAL |
| 210037683 | 210006954 | 1.65 | 67.9 | Curative (C) | 2014-10-02 | 2015-09-05 | UKALL14- Ph 2 Induction | N | N | 210011597 | UKALL2014 |
| 210037684 | 210006960 | 1.73 | 90.8 | Curative (C) | 2017-12-07 | 2017-12-08 | UKALL14- Ph 1 Induction | Y | N | 210011644 | UKALL2014 |
| 210037685 | 210025976 | 1.62 | 67 | Curative (C) | 2014-09-24 | 2015-01-21 | UKALL14- Intens/CNS Proph | N | null | 210011690 | UKALL2014 |
| 210037686 | 210006975 | null | 57.7 | Curative (C) | 2017-06-22 | 2017-06-23 | UKALL14- Ph 2 Induction | Y | N | 210011732 | UKALL2014 |
| 210037687 | 210018777 | 1.65 | null | Curative (C) | 2015-06-09 | 2015-12-09 | UKALL14- Maintenance + Imatinib | N | N | 210011746 | UKALL2014 |
| 210037688 | 210006986 | 1.88 | 87.3 | Curative (C) | 2015-08-01 | 2015-08-01 | UKALL14- Ph 2 Induction | Y | N | 210011774 | UKALL2014 |
| 210037689 | 210006997 | 1.89 | 53.3 | Adjuvant (A) | 2015-05-07 | 2016-08-16 | UKALL14- Ph 1 Induction | Y | N | 210011796 | UKALL2014 |
| 210037690 | 210018790 | null | 53.6 | Adjuvant (A) | 2017-03-17 | 2017-03-17 | UKALL14- Maintenance | Y | N | 210011798 | UKALL2014 |
| 210037691 | 210018800 | 1.82 | 83 | Not known (9) | 2018-04-03 | 2018-04-10 | UKALL14- Intens/CNS Proph | N | N | 210011898 | UKALL2014 |
| 210037693 | 210007027 | 1.74 | 76 | Curative (C) | 2019-02-02 | 2019-02-02 | UKALL14- Maintenance | Y | null | 210011965 | UKALL2014 |
| 210037694 | 210007032 | 1.83 | 82.5 | Curative (C) | 2015-06-28 | 2015-11-08 | UKALL14- Maintenance | Y | N | 210011976 | UKALL2014 |
| 210037695 | 210007040 | 1.54 | 75 | Curative (C) | 2014-08-10 | 2016-06-23 | UKALL14- Maintenance | Y | Y | 210012013 | UKALL2014 |
| 210037696 | 210007049 | 1.62 | 87 | Curative (C) | 2012-09-17 | 2015-09-13 | UKALL14- Cons Cycle 3 | 01 | N | 210012048 | UKALL2014 |
| 210037697 | 210007055 | 1.92 | 71 | Curative (C) | 2014-08-23 | 2014-08-30 | UKALL14- Maintenance | Y | N | 210012051 | UKALL2014 |
| 210037699 | 210018846 | 1.8 | 85.7 | Disease modification (D) | 2015-10-07 | 2015-11-11 | UKALL14- Cons Cycle 1 | null | N | 210012147 | UKALL2014 |
| 210037700 | 210033112 | 1.81 | 89 | Neo-adjuvant (N) | 2015-06-14 | 2015-07-09 | UKALL14- Ph 2 Induction | 02 | N | 210012198 | UKALL2014 |
| 210037701 | 210007101 | 1.81 | 71.2 | Curative (C) | 2015-09-21 | 2015-09-21 | UKALL14- Intens/CNS Proph | Y | N | 210012249 | UKALL2014 |
| 210037702 | 210007105 | 1.65 | 61.7 | Curative (C) | 2016-06-13 | 2018-10-17 | UKALL 14 TRIAL | Y | N | 210012268 | UKALL2014 |
| 210037703 | 210007108 | 1.83 | 94.2 | Curative (C) | 2018-08-03 | 2018-11-24 | UKALL14- Ph 1 Induction + Imatinib | Y | N | 210012274 | UKALL2014 |
| 210037704 | 210007113 | 1.69 | 95.799 | Neo-adjuvant (N) | 2014-11-17 | 2015-04-13 | UKALL14- Maintenance | Y | N | 210012295 | UKALL2014 |
| 210037705 | 210007121 | 1.75 | 53.6 | Curative (C) | 2014-12-19 | 2015-01-13 | UKALL14- Cons Cycle 2 | 01 | N | 210012299 | UKALL2014 |
| 210037706 | 210007130 | 1.77 | 71.2 | Curative (C) | 2018-10-01 | 2019-05-27 | UKALL 14 TRIAL | Y | N | 210012345 | UKALL2014 |
| 210037708 | 210018892 | 1.84 | 75 | Curative (C) | 2015-02-08 | 2015-02-08 | UKALL14- Cons Cycle 2 | 02 | N | 210012446 | UKALL2014 |
| 210037709 | 210007170 | 1.45 | 59.2 | Curative (C) | 2017-06-17 | 2017-08-31 | UKALL14- Intens/CNS Proph | 2 | N | 210012526 | UKALL2014 |
| 210037710 | 210007175 | 1.69 | 80.3 | Curative (C) | 2018-02-21 | 2018-06-06 | UKALL14- Ph 2 Induction | 1 | N | 210012572 | UKALL2014 |
| 210037712 | 210007226 | null | 13.8 | Curative (C) | 2017-04-06 | 2017-08-29 | ALL Ph+ve Imat1st/2nd Rind IIA Pasp | N | N | 210012772 | NOT MATCHED |
| 210037713 | 210007244 | 1.76 | 22.2 | Curative (C) | 2014-11-28 | 2016-08-17 | CNS Headstart II A Ind 4,5 int | Y | N | 210012870 | NOT MATCHED |
| 210037714 | 210007263 | null | 14.4 | Curative (C) | 2014-02-08 | 2014-02-10 | CYCLOPHOSPHAMIDE + CYTARABINE + MERCAPTOPURINE + METHOTREXATE + NELARABINE + PEGASPARAGINASE + VINCRISTINE | Y | N | 210012887 | NOT MATCHED |
| 210037715 | 210007278 | 0 | 32.6 | Curative (C) | 2017-05-15 | 2018-09-28 | PNET 4 HIT-SIOP Chemo + RT | 02 | N | 210012901 | NOT MATCHED |
| 210037716 | 210007282 | 0 | 8.6 | Curative (C) | 2018-10-16 | 2019-04-15 | null | N | N | 210012920 | NOT MATCHED |
| 210037717 | 210007294 | null | 7.9 | Curative (C) | null | 2018-01-10 | CNS ATRT ICE | 1 | Y | 210012963 | NOT MATCHED |
| 210037718 | 210007308 | null | 81 | Curative (C) | 2016-06-04 | 2017-09-03 | null | Y | N | 210012982 | NOT MATCHED |
| 210037719 | 210007312 | null | 14.4 | Curative (C) | 2017-09-14 | 2018-03-21 | CNS Headstart II A Ind 4,5 int | 1 | N | 210012988 | NOT MATCHED |
| 210037720 | 210033127 | null | 46 | Disease modification (D) | 2019-09-17 | 2019-10-09 | CNS High Grade Glioma PCV | Y | null | 210013000 | NOT MATCHED |
| 210037721 | 210007338 | 1.74 | 20.2 | Curative (C) | 2017-06-15 | 2017-09-13 | CNS Headstart II Myeloablation | 02 | N | 210013032 | NOT MATCHED |
| 210037722 | 210007344 | 1.83 | 26.2 | Curative (C) | 2016-07-22 | 2017-10-15 | CNS Medbl Std Risk weekly vinc+ xrt | N | N | 210013035 | NOT MATCHED |
| 210037723 | 210007354 | null | 19.5 | Curative (C) | 2015-09-23 | 2015-10-28 | CNS Epen2007 09 Baby Brn cisplatin | 2 | N | 210013045 | NOT MATCHED |